Supplemental Material for MSG L-00273-2023R1;Hemopexin Reverses Activation of Lung eIF2a and Decreases Mitochondrial Injury in Chlorine Exposed Mice by Sadis Matalon (13571353)

<i>MTHFR</i>677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial by Leopold K. Fezeu (5309333)

“…</p><p>Conclusion</p><p>Participants with the TT genotype exhibited a lower 5-year decrease in tHcy concentrations following a B-vitamin supplementation than did participants with the CC or CT genotype.…”

LiCl administered via 0.5% LiCl food pellets for 4 wks does not increase markers for autophagy in <i>Gfap-</i>R236H/+ mice. by Christine M. LaPash Daniels (796881)

LiCl administered via 0.5% LiCl food pellets for 8 wks decreases GFAP levels in surviving <i>Gfap</i>-R236H/+ mice. by Christine M. LaPash Daniels (796881)

“…(B) LiCl-treated +/+ and R236H/+ male mice had lower body weights compared with control-treated mice (N = 4–6 cages, 6–11 mice per group). (C) 0.5% LiCl treatment decreased GFAP in corpus callosum, parietal cortex including underlying white matter (cortex), brain stem, cerebellum, and cervical spinal cord of R236H/+ male mice as measured by ELISA (N = 3–4 cages, 4–6 mice per group). …”

Table1_Open Screw Placement in a 1.5 mm LCP Over a Fracture Gap Decreases Fatigue Life.docx by Sarah G. J. Alwen (5263049)

“…Objective<p>To investigate the influence of plate and screw hole position on the stability of simulated radial fractures stabilized with a 1.5 mm condylar locking compression plate (LCP).…”

Comparison of True Simulated Incidence Rate (Grey Lines) and Estimates Using Either Method (Black Lines; Both Give Same Results) when True Incidence Increases Steadily (A), Decreas... by Timothy B Hallett (42782)

Sexual hormone signaling differs between FVB/N-resistant and C57BL/6J-susceptible strains. by Ludwig Stenz (779897)

Raw data of the charts in Fig 5. by Kam Pui Tam (19746865)

Induction of duodenal and hepatic Cyps in VD₃ deficient mice after DEX treatment. by Kavya Annu (11587215)

Omega-3 enriched oils dose-dependently decrease macrophage lipid uptake. by Agua Sobrino (368634)

Maximum decreases in minute ventilation after fentanyl bolus administration (%). by Laurence M. Moss (12009078)

The CLP Population is Significantly Decreased in Arid3b null mice. by Jeffrey L. Kurkewich (3044211)

Decreased numbers of motor neurons in Tc1 and Dp(16)1Yey mice. by Sheona Watson-Scales (586942)

Intravenous treatment of naïve wild-type mice with PrP LSPCs decreased PrP^C mRNA and cell surface PrP^C protein at various time points. by Heather Bender (363996)

Suppression of endogenous human TRAM expression decreases R848 mediated <i>CCL5</i> and <i>IFN-β</i>, but not <i>TNF-α</i> expression. by Enda Shevlin (628477)

Dasatinib oral gavage PK raw data. by Kavya Annu (11587215)

Decreased expression of adipogenesis-related genes by baicalein in early stage of adipogenesis. by Yukari Nakao (3138795)

“…Cells were further incubated with the fluorescent 2-NBDG, and then observed under a fluorescence microscope. C, Quantification of glucose uptake in baicalein-treated, differentiated 3T3-L1 cells. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”